📝 Executive Summary
Rosen Law Firm has initiated an investigation into Disc Medicine, Inc. (NASDAQ: IRON) regarding potential securities claims. The inquiry centers on allegations that the biotechnology company may have issued materially misleading business information to its shareholders.